Scholarlink

Objective <p>Inflammation represents a key pathophysiological link between acute myocardial infarction and atrial fibrillation. Despite this, the platelet-to-lymphocyte ratio (PLR), as a composite inflammatory biomarker, remains underexplored for predicting new-onset atrial fibrillation (NOAF) specifically in patients with ST-segment elevation myocardial infarction (STEMI). This study aimed to evaluate the predictive value of PLR for in-hospital NOAF following percutaneous coronary intervention (PCI) in this population.</p> Methods <p>This was a single-center, retrospective observational study. A total of 335 patients diagnosed with STEMI at the Affiliated Hospital of Xuzhou Medical University from January 2023 to December 2023 were included. All patients underwent primary PCI within 12&#xa0;h of symptom onset and received continuous electrocardiographic monitoring during hospitalization. Logistic regression analysis and receiver operating characteristic (ROC) curves were used to assess the relationship between PLR and the incidence of NOAF during hospitalization in STEMI patients.</p> Results <p>Among the cohort, 30 patients (9.0%) developed NOAF during their hospital stay. Multivariable logistic regression, adjusted for potential confounders, identified age, systolic blood pressure, heart rate, and the coronary angiography-derived index of microcirculatory resistance (caIMR) as independent factors associated with NOAF. The PLR demonstrated good predictive performance for NOAF development, corresponding to an area under the curve (AUC) of 0.749 (95% CI: 0.664–0.834, <i>P</i> &lt; 0.001). Incorporating PLR into a baseline clinical model significantly improved risk prediction, with a NRI of 0.608 (<i>P</i> = 0.001) and an IDI of 0.071 (<i>P</i> = 0.004).</p> Conclusion <p>This study demonstrates that a high PLR is independently associated with in-hospital NOAF following primary PCI for STEMI. Furthermore, PLR offers significant improvement to the predictive capability of clinical risk models for NOAF, suggesting its utility in enhancing patient risk assessment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Predictive value of platelet-to-lymphocyte ratio for new-onset atrial fibrillation after percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月16日

查看全文
  • Yixuan Wu,
  • Jiahua Liu,
  • Lei Chen,
  • Xinjia Du,
  • Maochen Li,
  • Yanfei Ren,
  • Yuan Lu

摘要

Objective

Inflammation represents a key pathophysiological link between acute myocardial infarction and atrial fibrillation. Despite this, the platelet-to-lymphocyte ratio (PLR), as a composite inflammatory biomarker, remains underexplored for predicting new-onset atrial fibrillation (NOAF) specifically in patients with ST-segment elevation myocardial infarction (STEMI). This study aimed to evaluate the predictive value of PLR for in-hospital NOAF following percutaneous coronary intervention (PCI) in this population.

Methods

This was a single-center, retrospective observational study. A total of 335 patients diagnosed with STEMI at the Affiliated Hospital of Xuzhou Medical University from January 2023 to December 2023 were included. All patients underwent primary PCI within 12 h of symptom onset and received continuous electrocardiographic monitoring during hospitalization. Logistic regression analysis and receiver operating characteristic (ROC) curves were used to assess the relationship between PLR and the incidence of NOAF during hospitalization in STEMI patients.

Results

Among the cohort, 30 patients (9.0%) developed NOAF during their hospital stay. Multivariable logistic regression, adjusted for potential confounders, identified age, systolic blood pressure, heart rate, and the coronary angiography-derived index of microcirculatory resistance (caIMR) as independent factors associated with NOAF. The PLR demonstrated good predictive performance for NOAF development, corresponding to an area under the curve (AUC) of 0.749 (95% CI: 0.664–0.834, P < 0.001). Incorporating PLR into a baseline clinical model significantly improved risk prediction, with a NRI of 0.608 (P = 0.001) and an IDI of 0.071 (P = 0.004).

Conclusion

This study demonstrates that a high PLR is independently associated with in-hospital NOAF following primary PCI for STEMI. Furthermore, PLR offers significant improvement to the predictive capability of clinical risk models for NOAF, suggesting its utility in enhancing patient risk assessment.